Basket | Login | Register

 
 
 
 

Detailed programme and abstracts

#30AEC 2020

Detailed programme

Tuesday, 20 October

13.00-13.15 (Plenary) Opening ceremony

Welcome and introductory comments by

  • Iva Holmerová, Chairperson, Alzheimer Europe
  • Helen Rochford-Brennan, Chairperson, European Working Group of People with Dementia
  • Myrra Vernooij-Dassen, Chairperson, INTERDEM
  • Representative of European Commission

13.15-14.30 (Plenary) PL1. Round-table discussion: Dementia in a changing world

Moderator: Jean Georges (Alzheimer Europe)

With the participation of

  • Helen Rochford-Brennan (Ireland)
  • Mario Possenti (Italy)
  • Adelina Comas-Herrera (United Kingdom)
  • Lennert Steukers (Belgium)

15.00-16.15 (Breakout 1) Parallel session P1. Assistive technologies

Chairperson:

  • P1.1. Henriëtte VAN DER ROEST (Netherlands): Factors influencing implementation of Assistive Technologies for people with dementia; lessons learnt
  • P1.2. Rose-Marie Droës (Netherlands): Best Practice Guidance Technology in Dementia – Recommendations from INDUCT Network Updated
  • P1.3. Lucas Paletta (Austria): Playful multimodal activation with assessment of neuropsychological profiles in Alzheimer’s disease
  • P1.4. Taylor Dunn (Canada): Evaluating a symptom tracking mobile app for use in people with dementia
  • P1.5. David Krivec (Slovenia): TeNDER - Co-creation of the intelligent support system with patients, carers and professionals

15.00-16.15 (Breakout 2) Parallel session P2. Carers of people with dementia

Chairperson: Jayne Goodrick (United Kingdom)

  • P2.1. Kirsten Peetoom (Netherlands): RHAPSODY, a web-based multimedia, information, and skill-building program for carers of people with young-onset dementia in the Netherlands
  • P2.2. Tamara Backhouse (United Kingdom): Strategies to manage refusals of care: a comparison of family carer and care home staff experiences
  • P2.3. Nina Zerrar (France): Portrait of carers and dementia perceptions in France: evidence from Elders 4 (survey on longevity, dependency, risk and support)
  • P2.4. Áine Teahan (Ireland): Comparing carer burden in family carers of people with and without dementia: an Irish national dataset
  • P2.5. Marianne Lyngmose Nielsen (Denmark): A qualitative study of the everyday life and well-being among young relatives of parents with dementia

15.00-16.15 (Breakout 3) Parallel session P3. Neuronet

Chairperson: Carlos Díaz (Spain)

  • P3.1. Nigel Hughes (Belgium): Harmonisation of health data as a critical enabler for rapid actionable evidence
  • P3.2. Rodrigo Barnes (United Kingdom): Enabling analysis of pan-European datasets: the EPAD analytical database
  • P3.3. Anthony Brookes (United Kingdom): Data Discovery to support Data Sharing to support Data Analysis
  • P3.4. Manuela Rinaldi (Belgium): Adopting best practice on data sharing – report on Neuronet Working Group activities

This session is organised by Neuronet.

15.00-16.15 (Breakout 4) Parallel session P4. Interactive INTERDEM Academy Seminar: ethical dilemmas in research practice

Chairperson: Frans Verhey and Fania Dassen (Netherlands)

  • P4.1. Dorothee Horstkötter (Netherlands)
  • P4.2. Frans Verhey (Netherlands)
  • P4.3. Fania Dassen (Netherlands)

This session is organised by INTERDEM.

16.45-18.00 (Breakout 1) Parallel session P5. Post-diagnostic support

Chairperson:

  • P5.1. Shirley Evans (United Kingdom): How can Meeting Centres support people affected by dementia to adjust to change during a period of physical distancing?
  • P5.2. Matthew P. Janicki (USA): Planning dementia-capable community-based housing for adults with intellectual disability
  • P5.3. Alison Wheatley (United Kingdom): Exploring models of post diagnostic support in England
  • P5.4. Nikolas Dietzel (Germany): Needs of people with dementia and their caregivers: the Erlangen Needs Assessment in Dementia (ENA-D)
  • P5.5. Withdrawn

16.45-18.00 (Breakout 2) Parallel session P6. Minority ethnic groups

Chairperson:

  • P6.1. Ann Claeys (Belgium): What are barriers and facilitators to provide culturally sensitive care to older migrants with dementia?
  • P6.2. Sanne Franzen (Netherlands): Cross-cultural neuropsychological assessment in the European Union: a Delphi expert study
  • P6.3. Tim Schmachtenberg (Germany): Comparing national dementia plans and strategies in Europe – Is there a focus of care for people with dementia from a migration background?
  • P6.4. Saloua Berdai Chaouni (Belgium): Providing suitable care to older migrants with dementia in Belgium: perspective of family caregivers on accessibility and acceptability of professional dementia care.
  • P6.5. Siiri Jaakson (Finland): Cultural-sensitive Memory Work in Finland: The Memory Interpreter training program

16.45-18.00 (Breakout 3) Parallel session P7. Neuronet

Chairperson: Jean Georges (Luxembourg)

  • P7.1. Nathan Lea (United Kingdom): Data privacy and ethics in clinical research
  • P7.2. Pilar Cañabaté (Spain): Preservation of autonomy throughout dementia
  • P7.3. Sebastien Libert (United Kingdom): Remote monitoring and digital devices: ethical and patient privacy implications in the RADAR-AD project
  • P7.4. Angela Bradshaw (Luxembourg): Adopting best practice on patient privacy – report on Neuronet Working Group activities

This session is organised by Neuronet.

16.45-18.00 (Breakout 4) Parallel session P8. INTERDEM: Covid-19 social distancing and its challenges to social health in various settings and phases of life

Chairperson: Myrra Vernooij-Dassen (Netherlands)

  • P8.1. Myrra Vernooij-Dassen (Netherlands): Social distancing: protection and risk
  • P8.2. Dorota Szczesniak (Poland): Mental and social health consequences during pandemic in Poland
  • P8.3. Debbie Gerritsen (Netherlands): Allowing visitors back in the nursing home during the COVID-19 crisis: a Dutch national study into first experiences and impact on well-being
  • P8.4. Rabih Chattat (Italy): Community services for people with dementia and their caregivers: “We deal well during COVID-19 but “it is time to restart face to face meeting”

This session is organised by INTERDEM.

Wednesday, 21 October

08.45-10.15 (Plenary) Plenary session PL2: Diagnosis and medical management

  • PL2.1. Pierre Krolak-Salmon (France): Improving the diagnosis of neurocognitive disorders: implementing the recommendations of the 2nd European Joint Action on Dementia
  • PL2.2. Edo Richard (Netherlands): Ethical issues linked to the disclosure of diagnosis
  • PL2.3. Simon Lovestone (United Kingdom): The pharmacological treatment of Alzheimer’s disease. What have we learned in the past years?
  • PL2.4. Gunhild Waldemar (Denmark): Medical management issues in dementia. The new recommendations of the European Academy of Neurology

10.45-12.00 (Breakout 1) Parallel session P9. Psychosocial interventions

Chairperson:

  • P9.1. Katarzyna Lion (Australia): Can the Meeting Centre Support Programme reduce the burden of stigma among people with cognitive deficits?
  • P9.2. Margareta Halek (Germany): Development of a Theory of Change for an intervention aimed to improve sleep of people with dementia in nursing homes
  • P9.3. Hannah Christie (Netherlands): Implementing two evidence-based eHealth interventions for caregivers of people with dementia: an evaluation of Myinlife and Partner in Balance a municipality context
  • P9.4. Elyse Couch (United Kingdom): What are we measuring when we test non-drug interventions in MCI and mild dementia? A scoping review
  • P9.5. Harleen Rai (United Kingdom): A feasibility study of a randomised control trial to investigate the individual Cognitive Stimulation Therapy (iCST) application for people with dementia

10.45-12.00 (Breakout 2) Parallel session P10. Training of care professionals

Chairperson:

  • P10.1. Isabelle Latham (United Kingdom): What works is what matters: how care workers in care homes learn to care for people living with dementia
  • P10.2. Anna Jack-Waugh (United Kingdom): Scotland’s Dementia Champions programme: education with the experience of people with dementia at its heart
  • P10.3. Wendy Perry (United Kingdom): Developing person-centred care practice around the world through staff training and development
  • P10.4. Lindsey Collins (United Kingdom): Who is in charge? Exploring the multiple roles involved in supporting people with dementia and dysphagia
  • P10.5. Kenny Chui Chi Man (Hong Kong): "Listen to our voice too!" - the training needs of care providers in the residential care homes

10.45-12.00 (Breakout 3) Parallel session P11. AI approaches for dementia research, diagnosis and treatment

Chairperson: TBC

  • P11.1. Petra Ritter (Germany): Cloud-based simulation for personalised diagnosis and therapy
  • P11.2. Martin Hofmann-Apitius (Germany): Mapping mechanisms in AD and PD
  • P11.3. Viktor Jirsa (France): Biomarkers of healthy ageing from brain imaging data and prospective applications in AD

This session is organised by the H2020 Virtual Brain Cloud project

10.45-12.00 (Breakout 4) Parallel session P12. Ethnic minorities

Chairperson:Jochen René Thyrian (Germany)

  • P12.1. Catalina Tudose (Romania): Care situation of people with dementia in Romania
  • P12.2. Miriam Goudsmit (Netherlands): Dementia diagnostics and care for older migrants in the Netherlands: work in progress
  • P12.3. Naaheed Mukadam (United Kingdom): Consideration of diverse ethnic groups in memory service diagnostic procedures – results of the memory clinic survey
  • P12.4. Jessica Monsees and Tim Schmachtenberg (Germany): A European overview: presentation of preliminary results from the ‘EU-Atlas: Dementia & Migration’

This session is organised by DZNE.

13.00-14.00 (Breakout 1) Special symposium SS1. My second new life: adapting after COVID-19

Chairperson:Helen Rochford-Brennan (Ireland)

With the participation of:

  • Idalina Aguiar (Portugal)
  • Nina Balackova (Czech Republic)
  • Stefan Eriksson (Sweden)
  • Tomaž Gržinič (Slovenia)
  • Carol Hargreaves (United Kingdom)
  • Bernd Heise (Germany)
  • Angela Pototschnigg (Austria)
  • Chris Roberts (United Kingdom)
  • Geert van Laer (Belgium)

This special symposium is organised by the European Working Group of People with Dementia.

13.00-14.00 (Breakout 2) Special symposium SS2. Lessons from COVID-19 for AD health system readiness

Chairperson: Lydia Lanman (Switzerland)

With the participation of:

  • Soeren Mattke (USA)
  • Iva Holmerova (Czech Republic)
  • Chris Lynch (United Kingdom)
  • Maria Soto (France)
  • Martin Traber (Switzerland)

This special symposium is organised by Roche.

14.15-15.30 (Breakout 3) Parallel session P13. Diagnosis and disclosure

Chairperson:

  • P13.1. Janne Papma (Netherlands): The diagnostic and treatment challenges of behavioral and psychological symptoms in Alzheimer’s disease; a qualitative study in memory clinic practice
  • P13.2. Kasper Jørgensen (Denmark): BASIC – a new case finding instrument for dementia for use in clinical settings
  • P13.3. Stina Saunders (United Kingdom): Adjustment to test, risk and diagnostic disclosures in people with mild cognitive impairment: an observational cohort study
  • P13.4. Charalambos Themistocleous (USA): Improving the Diagnosis of Mild Cognitive Impairment in elderly individuals using a multifactorial automatic analysis of voice quality and prosody
  • P13.5. Sean Mackell (Ireland): What can a diagnosis of dementia tell me? A call for more research into sub-types of dementia

14.15-15.30 (Breakout 2) Parallel session P14. Awareness campaigns

Chairperson:

  • P14.1. Lisa Gernon (Ireland): Using our advocates’ voices to campaign for change: Pre Budget Submission 2020
  • P14.2. Katrine van den Bos (Denmark): Increasing awareness of dementia amongst supermarket employees and its customers - the case of REMA 1000.
  • P14.3. Lorène Gilly (France): Building an inclusive society: a national campaign led by France Alzheimer
  • P14.4. Philip Scheltens (Netherlands): Convincing the public that time really does matter in brain health
  • P14.5. Mignon Schichel (Netherlands): Age-friendly policies in a cross-national setting: are communities ready for healthy ageing?

14.15-15.30 (Breakout 3) Parallel session P15. Neuronet

Chairperson: Diana O’Rourke (United Kingdom)

  • P15.1. Diana O’Rourke (United Kingdom): Neuronet Regulatory Working Group – focus on the Decision Tool
  • P15.2. Jacoline Bouvy (United Kingdom): ROADMAP: Real-World Data supporting regulatory & health technology 
  • P15.3. Gill Farrar (United Kingdom): Experiences from the AMYPAD consortium on Regulatory/HTA interactions
  • P15.4. Marco Viceconti (Italy): The regulatory strategy of Mobilise-D for the qualification of wearable sensors to quantify mobility in drug trials

This session is organised by Neuronet.

14.15-15.30 (Breakout 4) Parallel session P16. Interdem: How assistive technology supported dementia care during COVID-19: European experience

Chairperson: Franka Meiland (Netherlands)

  • P16.1. Ana Barbosa (United Kingdom): Everyday technologies and people with dementia - access, use and adaptation
  • P16.2. Margareta Halek (Germany): To make best practice visible: Digital provision of practical recommendations for social participation in the context of Covid-19 in German nursing homes
  • P16.3. Lena Rosenberg (Sweden): Consequences of digital exclusion – reflections from Sweden
  • P16.4. Henriette van der Roest (Netherlands): Consequences of social isolation and uptake of communication technologies in Dutch nursing homes

This session is organised by Interdem.

15.45-17.15 (Plenary) Plenary session PL3: Building dementia-inclusive societies

  • PL3.1. Dianne Gove (Alzheimer Europe): Patient and public involvement approaches in dementia research. the experiences and contributions of the European Working Group of People with Dementia
  • PL3.2. Sabine Jansen (Germany): Promoting dementia-inclusive hospitals – the experience of the German Alzheimer’s association
  • PL3.3. Jacqueline Hoogendam (Netherlands). Making Dutch society more dementia-friendly: the learnings from the Dutch Dementia Strategy
  • PL3.4. John Keady (United Kingdom): The significance of neighbourhoods for people living with dementia and their care partners – key findings of the Neighbourhoods and dementia study

17.30-18.30 (Breakout 1) Special symposium SS3. Dementia and COVID-19

Chairperson:

  • SS3.1. Mercè Boada (Spain): Dementia care in times of COVID-19: telemedicine care at Memory Clinic, Fundació ACE Barcelona
  • SS3.2. Carolien Smits (Netherlands): Covid-19: Stress, anxiety and resilience in family carers caring for migrants with dementia
  • SS3.3. Nicola Cooper (United Kingdom): In the midst of a global pandemic, what have we learned about remote care approaches using technology?
  • SS3.4. Laura O’Philbin (Ireland): Psychosocial supports during Covid-19 for people with dementia and family carers

17.30-18.30 (Breakout 2) Special symposium SS4. It is time for European healthcare systems to prepare for Alzheimer’s breakthroughs

Chairperson: Cathy Smith (United Kingdom)

With the participation of:

  • Charles Scerri (Malta)
  • Sandra Gallina (Belgium)
  • Thomas Gebhart (Germany)
  • Philip Scheltens (Netherlands)
  • Antonella Santuccione Chadha (Switzerland)

This session is organised by EFPIA.

Thursday, 22 October

8.45-10.15 (Plenary) Plenary session PL4: From research and innovation to clinical and care practice

  • PL4.1. Carol Brayne (United Kingdom): Latest trends in the prevalence of dementia – are prevention messages having an effect?
  • PL4.2. Alexander Kurz (Germany): INDEED, an interprofessional intervention in dementia education for South-Eastern European countries
  • PL4.3. Dympna Casey (Ireland): Assistive technologies – how can research lead to better implementation and uptake?
  • PL4.4. Carlos Diaz (Spain): The neurodegeneration portfolio of the Innovative Medicines Initiative – from project results to sustainable assets

10.45-12.00 (Breakout 1) Parallel session P17. National dementia strategies

Chairperson:

  • P17.1. Nils Dahl (Germany): Introducing Germany's National Strategy on Dementia
  • P17.2. Louise Hopper (Ireland): Development of an Irish Dementia Registry including the identification of outcomes and data that matter most
  • P17.3. Seija Viljamaa (Finland): Finnish Age Strategy promotes implementation of memory- friendly practices
  • P17.4. Elisabeth Rappold (Austria): Dementia as Public Health Priority - current trends and best practice Austria
  • P17.5. Ella Robinson (United Kingdom): Building the Dementia Pathway

10.45-12.00 (Breakout 2) Parallel session P18. Acute and hospital care

Chairperson:

  • P18.1. Vincent Galibert (France): The Village Landais: an new innovating and caring structure in south-west of France
  • P18.2. Ioana Ioancio (Romania): Before the end of life in patients with Alzheimer's disease
  • P18.3. Katie Featherstone (United Kingdom): Cultures of care and the work of communicating the ‘rules of the ward’ to people living with dementia during a hospital admission and its consequences
  • P18.4. Helen Skinner (United Kingdom): 10 years of Alzheimer Scotland Dementia Nurse Consultants: Building bridges between Scottish Government, the NHS and the charitable sector
  • P18.5. Anders Møller Jensen (Denmark): Nurses' experiences of delivering acute orthopaedic care to patients with dementia

10.45-12.00 (Breakout 3) Parallel session P19. Dementia research and AI: ethical, legal and social implications

Chairperson: Angela Bradshaw (Luxembourg)

  • P19.1. Bernd Stahl (United Kingdom): Responsible AI: implications for brain research
  • P19.2. Michael Cepic (Austria): Legal considerations for data protection in AI-driven research
  • P19.3. Richard Milne (United Kingdom): Ethical challenges in the data-driven detection of dementia

This session is organised by the H2020 Virtual Brain Cloud project

10.45-12.00 (Breakout 4) Parallel session P20. BBDiag: Blood-based diagnosis of Alzheimer’s disease

Chairperson: Chima Eke (United Kingdom) and Fatemah Sakr (Germany)

  • P20.1. Genhua Pan (United Kingdom): Introduction, Blood-based diagnosis of Alzheimer’s disease
  • P20.2. Ourania Tzara (Denmark) and Chima Eke (United Kingdom): Novel biomarkers of Alzheimer’s disease
  • P20.3. Hina Abbasi and Jagriti Sethi (United Kingdom): Emerging technologies for Alzheimer’s disease: from novel detection protocols to business models

This session is sponsored by BBDiag

13.00-14.00 (Breakout 1) Special symposium SS5. From brain health to Alzheimer’s disease – Addressing the challenges early in the patient journey

Chairperson:Paola Barbarino

  • SS5.1. Marwan Sabbagh (xxx): The Diagnostic Process and Provider Engagement
  • SS5.2. Bengt Winblad (Sweden)
  • SS5.3. Frédéric Destrebecq
  • SS5.4. Jayne Goodrick (United Kingdom)

This session is sponsored by Biogen

13.00-14.00 (Breakout 2) Special symposium SS6. Presentation of a new European Academy of Neurology Guideline on medical management issues in dementia

Chairperson: Kristian Steen Frederiksen (Denmark)

With the participation of:

  • Christer Nilsson (Sweden)
  • Milica Kramberger
  • Ana Verdelho (Portugal)

This session is sponsored by EAN.

14.15-15.30 (Breakout 1) Parallel session P21. Risk factors and prevention

Chairperson:

  • P21.1. Avril Easton (Ireland): Nutrition - the lived experience of family carers
  • P21.2. Stephen Cutler (USA): On the relationship between hearing and memory: evidence from 51 countries
  • P21.3. Ana Maria Doscan (Romania): Anemia – a risk factor of Alzheimer’s disease in elderly people
  • P21.4. Guillaume Frasca (France): ALFA: a national pilot cohort to improve prevention
  • P21.5. Andreas Nagel (Germany): Risk of falling for people living with dementia at home: the Bavarian Dementia Survey (BayDem)

14.15-15.30 (Breakout 2) Parallel session P22. Involving people with dementia

Chairperson:

  • P22.1. Lewis Killin (United Kingdom): The Scottish Brain Health Register: an evidence-based approach to integrating research into clinical services.
  • P22.2. Karen Rennie (United Kingdom): Sexual expression in persons living with dementia and influence on nursing care
  • P22.3. Fiona Keogh (Ireland): Innovative methods for involving people with dementia and carers in the policy making process
  • P22.4. Cathal Blake (Ireland): Using public transport: experiences of people with dementia
  • P22.5. Hildegard Schmitt (Luxembourg): Experiences with the first supported self-help group in Luxembourg

14.15-15.30 (Breakout 3) Parallel session P23. Public-Private Partnerships in the post-COVID era

Moderator: Lennert Steukers (Belgium)

With the participation of

  • Dag Aarsland (Denmark)
  • Martin Hofmann-Apitius (Germany)
  • Walter Maetzler (Germany)
  • Craig Ritchie (United Kingdom)
  • Lynn Rochester (United Kingdom)
  • Pieter Jelle Visser (Netherlands)

This session is organised by Neuronet.

14.15-15.30 (Breakout 4) Parallel session P24. Impact of COVID-19 on dementia services and staff: inspiration for novel research

Chairperson: Martin Orrell (United Kingdom)

  • P24.1. Emma Wolverson (United Kingdom): Supporting inpatient mental health care in dementia during COVID-19
  • P24.2. Juan Luis Munoz Sanchez (Spain): Changes and new psychosocial and psychogeriatric approaches to people with dementia due COVID-19 outbreak in Spain
  • P24.3. Andrea Fabbo (Italy): The management of older people with dementia and COVID-19 in nursing home
  • P24.4. Iva Holmerova (Czech Republic): COVID-19 in long-term care settings – a task for future research and practice improvements

This session is organised by INTERDEM

16.00-17.15 (Plenary) Round table discussion: “Maintaining dementia as a European priority”

Moderator: Jim Pearson (United Kingdom)

With the participation of

  • Maria Carrillo (Alzheimer’s Association, USA)
  • Dan Chisholm (World Health Organization – European Region)
  • Nils Dahl (Ministry of Health, Germany)
  • Chris Roberts (European Working Group of People with Dementia, United Kingdom)
  • Charles Scerri (Malta Dementia Society)
  • Nicoline Tamsma (European Commission)

17.15-17.30 (Plenary) Closing ceremony

Closing comments and farewell by:

  • Chris Roberts, Chairperson-elect, European Working Group of People with Dementia
  • TBC, Chairperson-elect, Alzheimer Europe
  • Welcome to the 31st Alzheimer Europe Conference “Building bridges” in Bucharest, Romania

Quick oral presentations

Tuesday, 20 October

Quick oral presentations – QOP1. Care approaches

  • QOP1.1. Pilar Cañabete (Spain): Care in the times of COVID-19: counselling and intervention for vulnerable caregivers at Fundació ACE
  • QOP1.2. Withdrawn
  • QOP1.3. Joanne Brooke (United Kingdom): An innovative framework to support the development, implementation and evaluation of initiatives for prisoners with dementia
  • QOP1.4. Charlotte van Corven (Netherlands): Development and pilot study of the SPAN+ empowerment intervention for people with dementia living in the community
  • QOP1.5. Isabelle Latham (United Kingdom): Transforming care for people with advanced dementia in care homes: A process evaluation of Namaste Care
  • QOP1.6. David Neal (Netherlands): Demonstrated feasibility of the FindMyApps tablet-based intervention to promote social health in dementia
  • QOP1.7. TBC (Netherlands): Cost-consequence analysis of the Partner in Balance support program for informal carers of persons with dementia
  • QOP1.8. Astrid van der Schot (Netherlands): Psychosocial support for people with dementia and their caregivers: building bridges between consisting initiatives of care and needs
  • QOP1.9. Luisa Bartorelli (Italy): À la recherche du temps perdu: music therapy for people with Dementia (PwD) and their caregivers
  • QOP1.10. Phébe Das (Netherlands): Development and assessment of feasibility of psychosicial intervention SOCAV-in-Primary-Care
  • QOP1.11. Alys Griffiths (United Kingdom): The effectiveness of counselling for people with dementia and their families
  • QOP1.12. Mari-Liis Mägi (Estonia): Therapeutic dance movement for mild cognitive impairment patients

Wednesday, 21 October

Quick oral presentations – QOP2. Care services

  • QOP2.1. MOVED
  • QOP2.2. Birgit Dietz (Germany): Dementia-sensitive design of the physical environment in 10 care facilities in Bavaria
  • QOP2.3. Marjolein Thijssen (Netherlands): Success factors of dementia friendly initiatives using realist review and - evaluation
  • QOP2.4. Paolo Prolo (Switzerland): Sensory gardens in dementia care: will they survive the Covid-19 pandemics?
  • QOP2.5. Withdrawn
  • QOP2.6. Laura Cole (United Kingdom): Mapping models of residential respite services in England for people living with dementia and their carers
  • QOP2.7. Konstantina Anagnostopoulou (Greece): Ιmportance of ergonomic interventions at the living space
  • QOP2.8. Olivier Coupry (France): Improving night care for community dwelling people with dementia
  • QOP2.9. Lorène Gilly (France): France Alzheimer's vacation retreats
  • QOP2.10. Laura Cook (United Kingdom): Uncovering variation in care; the first English national memory service case note audit
  • QOP2.11. Adrianna Senczyszyn (Poland): The effects of Computerized Cognitive Training with Whole Body Cryotherapy on cognitive functions in seniors
  • QOP2.12. Soeren Mattke (USA): Blood biomarkers and cost and wait time for diagnosing treatment-eligible patients for Alzheimer’s disease

Quick oral presentations – QOP3. Medical and public health aspects

  • QOP3.1. Ann Nielsen (Denmark): BASIC-Q – a new case finding instrument for cognitive impairment aimed at community settings
  • QOP3.2. Stina Saunders (United Kingdom): The electronic Person-Specific Outcome Measure (ePSOM) development programme
  • QOP3.3. Elyse Couch (United Kingdom): Can an early diagnosis of dementia help people to live longer? A study of electronic health care records
  • QOP3.4. Tim Schmachtenberg (Germany): How is migration background considered in the treatment and care of people - a comparison of national dementia care guidelines in Europe
  • QOP3.5. Anders Lassen (Denmark): Do medicines regulators adequately address the public health needs in Alzheimer’s disease?
  • QOP3.6. Evi Zafeiridi (United Kingdom): Assessing the effect of prescription rate of anticholinergic medications on cognitive decline
  • QOP3.7. Evi Zafeiridi (United Kingdom):Risk factors for dementia: a retrospective study assessing predictors of dementia in Northern Ireland
  • QOP3.8. Anouk Geraets (Netherlands): The association of depression with structural brain markers and cognitive impairment: the Maastricht Study
  • QOP3.9. Sarah Bauermeister (United Kingdom): Traumatic brain injury, childhood adversity and the long-term effects on adult outcomes and dementia: a dementias platform UK (DPUK) Multi-Cohort Study
  • QOP3.10. Jurn Verschraegen (Belgium): With Alzheimer's in the Alps
  • QOP3.11. Lihui Pu (Australia): The course of quality of life and its predictors in nursing home residents with young-onset dementia
  • QOP3.12. Jeroen Bruinsma (Netherlands): Development of a web-based support program for caregivers of persons with frontotemporal dementia
  • QOP3.13. Yunus Msayib (United Kingdom): Representing a patient’s dementia pathology using an auto-generated Dementia Biomarkers Report

Thursday, 22 October

Quick oral presentations – QOP4. People

  • QOP4.1. Natassia Brenman (United Kingdom): “Jumping into the research”: Insights from the SPEAR study into motivations and expectations of participation in Alzheimer’s disease research
  • QOP4.2. Moved
  • QOP4.3. Lara Kürten (Germany): Predictors of caregiver depressiveness in dementia: results of the Bavarian Dementia Survey (BayDem)
  • QOP4.4. Sofia Koukouli (Greece): Factors affecting the perception of services by dementia informal caregivers in Greece: the role of familism
  • QOP4.5. Withdrawn
  • QOP4.6. Sandra Conijn (Netherlands): Experiences with online Alzheimer Cafes
  • QOP4.7. Sebastian Meuer (Germany): Behavioural and psychological symptoms in community dwelling people with dementia: Bavarian Dementia Survey
  • QOP4.8. Guillaume Frasca (France): France Alzheimer's Institute
  • QOP4.9. Mary Michael (USA): Voices of the Community: Spotlight on the Lived Experiences of Agitation
  • QOP4.10. Charlotte Stoner (United Kingdom): Beyond quality of life: the importance of positive psychology outcome measures
  • QOP4.11. Kim Bakker (Netherlands): Occupational therapy for older people with dementia and caregivers (COTiD)  within the multicultural context
  • QOP4.12. Hester Blok (Netherlands): Creating a Research Agenda with people with dementia and carers

Quick oral presentations – QOP5. Policy

  • QOP5.1. Štefanija  L. Zlobec (Slovenia): “Dementia Friendly Spots” a network providing information and support in local communities
  • QOP5.2. Rosie Dunn (United Kingdom): Reviewing the definition of multimorbidity and comorbidity in dementia care
  • QOP5.3. Maria do Rosário Zincke dos Reis (Portugal): The impact of advance directives in Portugal
  • QOP5.4. Julie Meerveld (Netherlands): The National Strategy of Alzheimer Nederland: how did we convince our minister of health to give priority to dementia?
  • QOP5.5. Filipa Landeiro (United Kingdom): Costs incurred by people with pre-dementia or dementia
  • QOP5.6. Craig Ritchie (United Kingdom): Brain Health Scotland: a national initiative to reduce incident dementia
  • QOP5.7. Lewis Killin (United Kingdom): The Scottish Brain Health Register
  • QOP5.8. Chris Lynch (United Kingdom): From plan to impact III, progress towards the WHO Global action plan on dementia
  • QOP5.9. Áine Teahan (Ireland): Family carers' preferences for psychosocial supports: informing policy using nominal group technique
  • QOP5.10. Kristina Holm (Germany): Information sources for informal caregivers in rural vs. urban areas: the Bavarian Dementia Survey (BayDem)
  • QOP5.11. Noémie Pasquier (Switzerland): How do support providers assess the needs of informal caregivers of persons with dementia?
  • QOP5.12. Sandrine Pihet (Switzerland): An online tool to assess the needs of informal dementia caregivers and refer them to the relevant support services

Poster presentations

Tuesday, 20 October

Poster presentations – PO1. Care approaches

  • PO1.1. Katrin Krah (Germany): Certification-D – testing and certifying products for people with dementia at the ARCK Living Lab in Krefeld, Germany
  • PO1.2. Allan Bregola (United Kingdom): Apathy and use of Assistive Technology (AT) as predictors of  functional performance in Alzheimer’s disease
  • PO1.3. Allan Bregola (United Kingdom): Does carer management style predict functional performance in medication management in Alzheimer’s disease?
  • PO1.4. Niamh Gallagher (Ireland): Using Fitbit to record activity levels and sleep quality in people with dementia
  • PO1.5. Withdrawn
  • PO1.6. Nellie Gospodinova (Romania): The promise of virtual reality in elderly care: VirtuAAL* project results
  • PO1.7. Magdalena Velciu (Romania): The benefit of using indoor technology to decrease the complex effect of elderly social isolation
  • PO1.8. Samantha Dequanter (Belgium, Canada): Perceptions of health care professionals on e-Health solutions for cognitively impaired community-dwelling older adults and informal caregivers in Flanders (BE) and Québec (CA)
  • PO1.9. Marianna Tsatali (Greece): RECage project: a prospective cohort study for coping with behavioral and psychological symptoms of dementia
  • PO1.10. Samantha Pradelli (Italy): “Living well with dementia” groups in Italy
  • PO1.11. Rikke Gregersen (Denmark): Interactive technologies supporting cognition in people with dementia – preliminary results!
  • PO1.12. Christian Wrede (Netherlands): Exploring views and needs of (in)formal caregivers towards unobtrusive monitoring in home-based dementia care
  • PO1.13. Lucas Paletta (Austria): Virtual reality based mindfulness training, sensory activation and assessment for dementia care
  • PO1.14. Wei Qi Koh (Ireland): Exploring the  impact of a robotic cat for older adults and people with dementia: a scoping review
  • PO1.15. Jean-Bernard Mabire (France): Raising awareness of the use of touchscreen tablets among people with dementia in day care centre
  • PO1.16. Oana Popoiu (Romania): Smart big data platform to offer evidence-based personalized support for healthy and independent living at home
  • PO1.17. Hanne Peoples (Denmark): Collaborative partnership on the development of tools to promote personalized communication about everyday technology
  • PO1.18. Dorien Oostra (Netherlands): Development of a digital resilience monitor for informal caregivers of persons with dementia to prevent crises
  • PO1.19. Lucia Carragher (Ireland): A companion robot pet; the experiences of residents living with dementia in long-term care
  • PO1.20. Wei Qi Koh (Ireland): Understanding the barriers and facilitators affecting the implementation of social robots for older adults including people with dementia: a scoping review
  • PO1.21. Silka Dawn Freiesleben (Germany): Promoting the adoption of wearable GPS technologies in dementia care: key lessons from focus group interviews with business, research and healthcare professionals
  • PO1.22. Andrei Voicu (Romania): Impact of assistive technologies on cognitive decline among senior mild cognitive impairment patients
  • PO1.23. Lucas Paletta (Austria): The potential of augmented reality services for assisting activities of daily living in dementia care
  • PO1.24. Gayle Henry (United Kingdom): Facilitating palliative care for people with dementia: recognising signs and symptoms of end stage dementia
  • PO1.25. Sara Laureen Bartels (Netherlands): Feasibility and usability of smart-phone based experience sampling  in people with MCI
  • PO1.26. Cathy Murphy (United Kingdom): Causes and consequences of incontinence problems for people living at home with dementia
  • PO1.27. Sanna-Kaisa Huhtala (Finland): Making an impact in the third sector
  • PO1.28. Štefanija L. Zlobec (Slovenia): DS-AGEING - cognitive training programme for healthy and well-ageing of people with Down Syndrome
  • PO1.29. Julieta Camino (United Kingdom): Interaction style and assistance given by carers of people with dementia during the performance of daily tasks. A novel observation scale
  • PO1.30. Petra Boersma (Netherlands): The added value of art for caregivers and artists and people with dementia living in nursing homes
  • PO1.31. Grace O’Sullivan (Ireland): Experiences of people with dementia and carers participating in a complex psychosocial intervention (CREST)
  • PO1.32. Priscilla Doyle (Ireland): Exploring the feasibility of a complex psychosocial intervention (CREST) for people with dementia and carers
  • PO1.33. Josephine Rose Tan (Netherlands): Seen as a Person: digital art promoting social interaction between dementia residents, families and carers
  • PO1.34. Withdrawn
  • PO1.36. Rhoda Macrae (United Kingdom): The social impact of participating in sport for people living with dementia
  • PO1.37. Diana Burgui (Ireland): Physical and mental wellbeing during the Covid-19 crisis
  • PO1.38. Clelia d’Anastasio (Italy): Use of social media and virtual gathering to face Covid-19 outbreak among persons with dementia and their carers
  • O1.39. Golnaz Atefi (Netherlands): The potential utility of acceptance and commitment therapy for informal caregivers of people with dementia: a systematic review

Wednesday, 21 October

Poster presentations – PO2. Care services

  • PO2.1. Hana Bláhová (Czech Republic): The needs of people living with dementia in acute hospital care
  • PO2.2. Alicia Diaz-Gil (United Kingdom): Caring for people with dementia in perioperative environments: the experiences of healthcare professionals
  • PO2.3. Lori Bourke (United Kingdom): Investigating the association between ward and discharge discussions regarding support needs for people with dementia.
  • PO2.4. Withdrawn
  • PO2.5. Withdrawn
  • PO2.6. Caroline Bartle (United Kingdom): Improving impact of learning on practice

Poster presentations – PO3. Medical and public health aspects

  • P03.1. Antonio Oliveros Cid (Spain): Insight and awareness at the time of diagnosis and progression of dementia in Alzheimer’s disease patients
  • PO3.2. Antonio Oliveros Cid (Spain): Utility of TAU-PET in individual cases of Alzheimer's disease patients
  • PO3.3. Antonio Oliveros Cid (Spain): Contribution of CSF biomarkers in the diagnosis of Alzheimer's disease
  • PO3.4. Iris Linden (Netherlands): Preferences of people with memory complaints and their significant others regarding a timely diagnostic process for dementia and decision-making in that process: a systematic integrative review
  • PO3.5. Antonio Oliveros Cid (Spain): Epilepsy profile in Alzheimer's disease patients
  • PO3.6. Hui-Jer Chou (Taiwan): The extrapyramidal syndrome risk of herbal medicine and antipsychotics combined usage in dementia patients
  • PO3.7. Marta Lenart (Poland): Systematic mapping review on factors impacting the pathway from health to dementia
  • PO3.8. Elena Garcia Arcelay (Spain): Assessing knowledge & perceptions towards people with Alzheimer’s disease among employees of a pharma company
  • PO3.9. Laurent Lefebvre (Belgium): The functional communication scale for patients: a French test evaluating residual communication skills
  • PO3.10. Mihaela Cosmina Niculescu (Romania): Ethical issues considering alzheimer`s disease. diagnosis disclosure in the patient/family/caregiver relationship
  • PO3.11. Bogdan Ivanov (Romania): What to eat and what nutritional supplements intake you need to reduce your risk of Alzheimer’s disease
  • PO3.12. Withdrawn
  • PO3.13. Sweelin Chew (Finland): ADAIR – novel biomarker discovery to unravel the link of air pollution and Alzheimer’s disease
  • PO3.14. Sarah Bauermeister (United Kingdom): Dementias Platform UK (DPUK): facilitating multi-modal digital data access for dementias research
  • PO3.15. Ana Maria Doscan (Romania): Professional Stress – a major risk factor in Alzheimer’s disease
  • PO3.16. Chiara Brück (Netherlands): The development of a microsimulation model to predict the future burden of dementia
  • PO3.17. Salvatore Bazzano (Italy): COVID-19 era: new technological strategies to manage Behavioral and Psychological Symptoms in Dementia (BPSD)
  • PO3.18. Marthe Smedinga (Netherlands): Should doctors offer biomarker testing to those with cognitive complaints who are afraid to develop Alzheimer’s dementia?
  • PO3.19. Marijn Muurling (Netherlands): Remote assessment of Alzheimer’s Disease: the RADAR-AD study

Thursday, 22 October

Poster presentations – PO4. People

  • PO4.1. Tamara Backhouse (United Kingdom): Home-care workers experiences of looking after people with dementia: a qualitative interview study
  • PO4.2. Joost Wammes (Netherlands): Prioritizing care and support characteristics for persons with dementia and informal caregivers to prolong community living
  • PO4.3. Fiona Keogh (Ireland): Developing guidelines for involving people with dementia in policy, consultation and conference activities
  • PO4.4. Verena C. Tatzer (Austria): “Creating enabling environments in a library and in the community – the project “The Dementia-friendly library Wiener Neustadt”
  • PO4.5. Manik Kharismayekti (Netherlands): Well-being from a migration perspective of older persons with an Indonesian background in The Netherlands
  • PO4.6. Lucía Ruanova (Spain): Together in care program
  • PO4.7. Withdrawn
  • PO4.8. Withdrawn
  • PO4.9. Susan Holland (United Kingdom): Carers' Academy
  • PO4.10. Stephanie Kipfer (Switzerland): Adapting a psycho-educative intervention to facilitate the participation of informal caregivers
  • PO4.11. Withdrawn
  • PO4.12. David Krivec (Slovenia): We are still together - adapting the activities and services during pandemic
  • PO4.13. Jean-Bernard Mabire (France): Creating a user touchscreen tablets guide for and with people with dementia
  • PO4.14. Teun Toebes (Netherlands): Encourage in life
  • PO4.15. Alessandro Bosco (United Kingdom): Narrative inquiry on case studies of crisis in dementia
  • PO4.16. Harleen Rai (United Kingdom): Improving the involvement of people with dementia in developing technology–based interventions: a narrative synthesis review and best practice guidelines
  • PO4.17. Mervi Issakainen (Finland): Prerequisites for mental wellbeing among people facing early onset dementia while still working: Finnish results from the MCI@Work project
  • PO4.18. Katie Gambier-Ross (United Kingdom): Staying Safe 'Going Out'- the experience of people affected by dementia
  • PO4.19. Katie Gambier-Ross (United Kingdom): The importance of international collaborations to address wayfinding and missing persons incidents
  • PO4.20. Claudio di Lorito (United Kingdom): The experience of caring for someone living with dementia: a mixed-methods study on caregiver strain, quality of life and perceived health
  • PO4.21. Rosa Almeida (Spain): Value driven participation in co-creation of the virtual coach CAPTAIN to support independent living at home
  • PO4.22. Jessica Monsees (Germany): Intercultural care for people with a migration background with dementia
  • PO4.23. Bosma Corina (Netherlands): Shaking professionals’ caregiving foundations: experiences with problem behaviour in people with dementia from minority ethnic groups
  • PO4.24. Amalia Fonk Utomo (Netherlands): Adapting Alzheimer Nederland handbook “Dementie en Nu?” to Bahasa Indonesia and culture “Demensia Lalu Bagaimana?”

Poster presentations – PO5. Policy

  • PO5.1. Maria Maćkowiak (Poland): Understanding of dementia in Poland - lexical semantic analysis of otępienie (English 'dementia') in Polish language
  • PO5.2. Chialin Lin (Taiwan): Informed consent and influence factors of acupuncture treatment for patients with dementia
  • PO5.3. Federica Boschi (Italy): Improving the quality of life of people with dementia living in nursing homes: the accreditation process of care home providers in Forlì
  • PO5.4. Withdrawn
  • PO5.5. Amalia Fonk Utomo (Netherlands): Involving indonesian students and association in the Netherlands
  • PO5.6. Tonino Rovatti (Italy): First steps to Dementia Friendly Community in Formigine: measure of community attitude towards people living with dementia
  • PO5.7. Sekar Galuh (Netherlands): The Responses of Pasar Indonesia Raya visitors after experiencing Dementia Virtual Reality in The Netherlands
  • PO5.8. Tania Setiadi (Netherlands): The program, knowledge, awareness and attitude project: stichting Alzheimer Indonesia Nederland’s evaluation
  • PO5.9. Nélida Aguiar (Portugal): Support measures for informal caregivers of people with dementia
  • PO5.10. Agnes Egervari (Hungary): Dementia Action Plan: focusing on prevention and families
  • PO5.11. Michael Reichold (Germany): Digital services for dementia from the perspective of service providers: digiDEM Bayern
  • PO5.12. Nélida Aguiar (Portugal): Full-time caregiving families

 

 
 

Last Updated: Wednesday 30 September 2020

 

 
  • Acknowledgements

    The 30th AE Conference received funding under an operating grant from the European Union’s Health Programme (2014-2020). Alzheimer Europe gratefully acknowledges the support of all conference sponsors.
  • European Union
  • Roche
 
 

Options